Verrica Pharmaceuticals Inc. investors can proceed as a class in their suit over allegedly concealed ongoing drug production problems that delayed FDA approval, a federal court ruled.

Becton Dickinson & Co. and C.R. Bard Inc. largely lost their bid for summary judgment in a bellwether plaintiff’s suit alleging the companies’ implanted port catheters were defective and led to medical complications.

Components listed separately in patent claims must be different physical parts of a device—not one doing double duty—the Federal Circuit said in upholding a decision overturning a jury verdict that Kurin Inc. infringed a Magnolia Medical Technologies Inc. blood-testing device patent.

French drugmaker Servier agreed to buy US biotech Day One Biopharmaceuticals Inc. for about $2.5 billion in cash to expand its portfolio of treatments for rare cancers.

Indiana’s abortion law has been halted insofar as it violates the rights of a certified class whose members don’t share the Christian religious belief that life begins at conception, a state trial court said.

Kristi Noem’s 13-month tenure leading the Department of Homeland Security was marked by controversy. But it wasn’t the two American citizens’ deaths at the hands of federal immigration agents that ultimately cost her the job.